U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 4

1.
Figure 2.

Figure 2. From: Synthesis of chiral pyrazolo[4,3-e][1,2,4]triazine sulfonamides with tyrosinase and urease inhibitory activity.

a) Lineweaver–Burk plots for the inhibition of mushroom tyrosinase in the presence of compound (8j). Concentrations of (8j) were 0, 14, 28 and 55.8 μM, respectively. Substrate l -DOPA Concentrations were 0.062, 0.125, 0.25, 0.5, 1 and 2 mM, respectively. b) The Dixon plot of the reciprocal of initial velocities versus various concentrations of compound (8j) at fixed substrate concentration.

Mariusz Mojzych, et al. J Enzyme Inhib Med Chem. 2017;32(1):99-105.
2.
Figure 3.

Figure 3. From: Synthesis of chiral pyrazolo[4,3-e][1,2,4]triazine sulfonamides with tyrosinase and urease inhibitory activity.

a) Double reciprocal Lineweaver–Burk plots for the inhibition of Jack bean urease in the presence of compound (8a). Concentrations of (8a) were 0, 0.125, 0.25 and 0.5 μM, respectively. Substrate urea concentrations were 3.12, 6.25, 12.5, 25, 50 and 100 mM, respectively. b) The secondary replot of the Lineweaver–Burk plot, 1/V (y-intercept) of a) versus various concentrations of (8a). c) The Dixon plot of the reciprocal of the initial velocities versus various concentrations of compound (8a) at fixed substrate concentration.

Mariusz Mojzych, et al. J Enzyme Inhib Med Chem. 2017;32(1):99-105.
3.
Figure 1.

Figure 1. From: Synthesis of chiral pyrazolo[4,3-e][1,2,4]triazine sulfonamides with tyrosinase and urease inhibitory activity.

a) Lineweaver–Burk plots for the inhibition of mushroom tyrosinase in the presence of compound (8b). Concentrations of (8b) were 0, 15, 30, 61, 123 and 247 μM, respectively. Substrate l -DOPA Concentrations were 0.125, 0.25, 0.5, 1 and 2 mM, respectively. b) The secondary replot of the Lineweaver–Burk plot, 1/V (y-intercept) of a) versus various concentrations of (8b). c) The Dixon plot of the reciprocal of the initial velocities versus various concentrations of compound (8b) at fixed substrate concentration.

Mariusz Mojzych, et al. J Enzyme Inhib Med Chem. 2017;32(1):99-105.
4.
Scheme 1.

Scheme 1. From: Synthesis of chiral pyrazolo[4,3-e][1,2,4]triazine sulfonamides with tyrosinase and urease inhibitory activity.

Synthetic pathway to the sulfonamides 8a–i. Reagents and conditions: (a) CH3CH2NO2, KOH, DMSO, 2 h, 80–86%; (b) Na2S2O4, H2O/dioxane, rt, 12 h, 55–65%; (c) CH3NH–NH2, PTSA, EtOH, rt, 1 h, 50–55%; (d) method A: 10% HCl, EtOH, reflux, 1 h, 58–61%; method B: PTSA, 140 °C, 1 min, 61%; (e) ethoxyphenylboronic acid, Pd(PPh3)4, CuMeSal, THF, Ar, reflux, overnight, 75–80%; (f); ClSO3H, 0 °C to rt, 2 h, 75–95%; (g) appropriate amine, anhydrous MeCN, rt, overnight, 72–93%.

Mariusz Mojzych, et al. J Enzyme Inhib Med Chem. 2017;32(1):99-105.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center